Skip to main content
Fig. 2 | Journal of Neuroinflammation

Fig. 2

From: Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study

Fig. 2

Change in CSF parameters at 24-week follow-up. A: Change in CSF WBC at 24-week follow-up. B: Change in CSF protein at 24-week follow-up. Rapid reduction in the WBC and protein level in CSF was observed following lenalidomide therapy. Red dotted lines represent the range of normal reference values for the WBC count and protein level in CSF. W: week. WBC: white blood cell; CSF: cerebrospinal fluid

Back to article page